ofev logo

Improving early diagnosis in RA-ILD patients

RA-ILD RISK CALCULATOR:

RA-ILD represents an unmet diagnostic clinical need. Interstitial lung disease (ILD) is one of the most common and severe extra-articular manifestations of rheumatoid arthritis (RA)1-4

home hero
icon patient

RA patients experience ILD within 5-10 years of disease progression1-7

icon second

ILD is 2nd leading cause of premature death in RA, after cardiovascular complications1-4,8

There are currently no recommendations on ILD screening in either the initial assessment or in the follow-up of RA patients.

The RA-EPIDSER expert consensus group consisting of 18 expert panelists including 9 pulmonologists and 9 rheumatologists proposed a RA-ILD risk scoring with selective screening criteria and a screening algorithm, including recommendations for complementary tests to be carried out in the different clinical scenarios.

The RA-ILD risk calculator provides a common strategy between rheumatologists and pulmonologists to improve the early diagnosis and quality of life of patients with RA-ILD and aid in clinical decision making.9

References

  • 1.
    Farquhar H, et al. Semin Respir Crit Care Med. 2019;40:194–207.
  • 2.
    Yunt ZX, Solomon JJ. Rheum Dis Clin North Am. 2015;41:225–36.
  • 3.
    Spagnolo P, et al. Arthritis Rheumatol. 2018;70:1544–54.
  • 4.
    Bongartz T, et al. Arthritis Rheum. 2010;62:1583–9.
  • 5.
    Shidara K, et al. Mod Rheumatol. 2010;20:280–6.
  • 6.
    Koduri G, et al. Rheumatology (Oxford). 2010;49:1483–9.
  • 7.
    Duarte AC, et al. Rheumatology (Oxford). 2019;58:2031–8.
  • 8.
    Hyldgaard C, Hilberg O, et al. Ann Rheum Dis. 2017;76:1700–6.
  • 9.
    Narvaez J, et al. Reumatol Clin. 2023;19:74-81